KTB Ventures
VC Fund
San Francisco, United States
KTB Ventures is a VC fund in San Francisco focused on Software and Wireless. Founded in 1981 as one of the first venture capital firms in Korea, KTB has consistently proven itself as a premier investment company. Throughout KTB's over 30 years of history, more than 250 portfolio companies of KTB went IPO in Korea and overseas, accounting for over 10% of Korean IPOs. The venture capital entity in Korea and China areunder the name KTB Network and the entity in the US is under KTB Ventures.
- Total investments:
- 50
- Last investment:
- Lead investor:
- 26%
Last updated:
For AI agents: llms.txt
Industries KTB Ventures invests in
Stages KTB Ventures invests in
Countries KTB Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1M–$16M
- Series B
- $4.8M–$40M
Investment Focus
Industry
- Software 7 (14%)
- Wireless 7 (14%)
- Mobile 6 (12%)
- Video 4 (8%)
- Medical 4 (8%)
Stage
- Series B 16 (32%)
- Funding Round 11 (22%)
- Series A 7 (14%)
- Series C 7 (14%)
- Series D 4 (8%)
Country
- United States 17 (34%)
- China 12 (24%)
- South Korea 5 (10%)
- India 2 (4%)
- Taiwan 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Byung Chul Ko
Director
|
Director | Total investments: 0 | Find email | |
Chang Kyu Kim
Executive Director of Invesment Screening
|
Executive Director of Invesment Screening | Total investments: 0 | Find email | |
|
Chul Hong Kim
Director
|
Director | Total investments: 0 | Find email | |
|
Do Chung
Team Member
|
Team Member | Total investments: 0 | Find email | |
|
Dong Hyun Lim
Director
|
Director | Total investments: 3 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Travelio
|
Travelio is an online short-term home rental marketplace that provides apartments, villas, and houses. Its platform allows its clients to reserve and choose houses, villas, and apartments online. Travelio was founded in March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli. | Series C / Apr 10, 2023 | |
UPRISE
|
UPRISE creates self-driving investment services. | $20.5M / Series C / Dec 08, 2021 | |
blinkit
|
Grofers is a low-price online supermarket that gets products across categories like grocery, beauty, and wellness, household care, baby care, pet care delivered to your doorstep. Grofers provides over 3,000 products at prices lower than supermarkets every day.Grofers currently operates in a total of 26 cities across India: Agra, Ahmedabad,Bengaluru, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi NCR, Hyderabad, Indore, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Mumbai, Mysuru, Nagpur, Nashik, Pune, Rajkot, Surat, Vadodara, and Visakhapatnam. | $16.7M / Series G / Sep 29, 2021 | |
Nuanwa Technology
|
Nuanwa Technology is a health insurance technology platform. The company is positioned in the field of health insurance technology, mainly serving insurance companies and Internet platforms, providing products customization services, risk control, claims services, system services and other solutions for its health insurance business. Medicalecology and health insurance, open up barriers to medical data information. | Series A / Aug 01, 2021 | |
|
blinkit
|
Grofers is a low-price online supermarket that gets products across categories like grocery, beauty, and wellness, household care, baby care, pet care delivered to your doorstep. Grofers provides over 3,000 products at prices lower than supermarkets every day.Grofers currently operates in a total of 26 cities across India: Agra, Ahmedabad,Bengaluru, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi NCR, Hyderabad, Indore, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Mumbai, Mysuru, Nagpur, Nashik, Pune, Rajkot, Surat, Vadodara, and Visakhapatnam. | $55M / Nov 13, 2020 | |
|
blinkit
|
Grofers is a low-price online supermarket that gets products across categories like grocery, beauty, and wellness, household care, baby care, pet care delivered to your doorstep. Grofers provides over 3,000 products at prices lower than supermarkets every day.Grofers currently operates in a total of 26 cities across India: Agra, Ahmedabad,Bengaluru, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi NCR, Hyderabad, Indore, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Mumbai, Mysuru, Nagpur, Nashik, Pune, Rajkot, Surat, Vadodara, and Visakhapatnam. | $70M / Series F / Aug 19, 2019 | |
|
blinkit
|
Grofers is a low-price online supermarket that gets products across categories like grocery, beauty, and wellness, household care, baby care, pet care delivered to your doorstep. Grofers provides over 3,000 products at prices lower than supermarkets every day.Grofers currently operates in a total of 26 cities across India: Agra, Ahmedabad,Bengaluru, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi NCR, Hyderabad, Indore, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Mumbai, Mysuru, Nagpur, Nashik, Pune, Rajkot, Surat, Vadodara, and Visakhapatnam. | $220M / Series F / May 15, 2019 | |
ORIG3N
|
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts. | $14.4M / Series B / Jul 12, 2018 | |
Moloco
|
Moloco offers programmatic advertising solutions to help optimize the client's acquisition, retention, and monetization campaigns. The company's focus is on delivering quality and scale to its advertisers and publishers has been recognized by the industry. The company is heavily tech-driven with top talents from Google, Amazon, Twitter,and Goldman Sachs.Founded in 2013 with a vision to empower mobile businesses to thrive. | $11M / Series B / May 10, 2018 | |
CARsgen Therapeutics
|
CARsgen is a leading clinical-stage immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has partnership with Shanghai Cancer Institute and Shanghai Renji Hospital. The company is leading the first tier of CAR-T development, bycompleting World’s first hepatocellular carcinoma (HCC) and China’s exclusive glioblastoma multiforme (GBM) dose ascending injection tests. Funded by leading venture capital firm BVCF, CARsgen is well-positioned to bring a novel cancer therapeutics to the market in China and worldwide. | $60M / Series C / Mar 02, 2018 | |
| See all 50 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does KTB Ventures invest in?
KTB Ventures invests primarily in Software, Wireless and Mobile startups, most often at Series B and Funding Round stage. Most of the 50 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is KTB Ventures's check size?
KTB Ventures typically joins rounds of $1M–$16M at Series A and $4.8M–$40M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds KTB Ventures participates in.
How do I contact KTB Ventures?
Public channels for KTB Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KTB Ventures?
The team at KTB Ventures includes Byung Chul Ko (Director), Chang Kyu Kim (Executive Director of Invesment Screening) and Chul Hong Kim (Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
